Michael S. Anger

842 total citations · 1 hit paper
23 papers, 515 citations indexed

About

Michael S. Anger is a scholar working on Nephrology, Surgery and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Michael S. Anger has authored 23 papers receiving a total of 515 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Nephrology, 6 papers in Surgery and 5 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Michael S. Anger's work include Dialysis and Renal Disease Management (11 papers), Parathyroid Disorders and Treatments (6 papers) and Muscle and Compartmental Disorders (3 papers). Michael S. Anger is often cited by papers focused on Dialysis and Renal Disease Management (11 papers), Parathyroid Disorders and Treatments (6 papers) and Muscle and Compartmental Disorders (3 papers). Michael S. Anger collaborates with scholars based in United States, Germany and Belgium. Michael S. Anger's co-authors include Charles R. Nolan, Stephen P. Kelleher, Philipp Lirk, Girish P. Joshi, Hélène Beloeil, Johan Ræder, Marc Van de Velde, Steven Zeig, Linda Ficociello and Claudy Mullon and has published in prestigious journals such as New England Journal of Medicine, Kidney International and Journal of the American Society of Nephrology.

In The Last Decade

Michael S. Anger

21 papers receiving 479 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

PROSPECT guideline for total hip arthroplasty: a systematic review and procedure‐specific postoperative pain management recommendations

2021 144 citations Michael S. Anger, Hélène Beloeil et al. Anaesthesia profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Michael S. Anger United States	11	190	183	61	57	54	23	515
J. Unger Germany	15	79 0.4×	267 1.5×	62 1.0×	85 1.5×	64 1.2×	71	780
Jonathan Halevy Israel	14	62 0.3×	129 0.7×	69 1.1×	123 2.2×	10 0.2×	45	664
Joerg Latus Germany	19	361 1.9×	219 1.2×	150 2.5×	170 3.0×	80 1.5×	73	929
Hailong Wang China	13	73 0.4×	124 0.7×	115 1.9×	98 1.7×	11 0.2×	43	490
Cannizzaro Ma Italy	15	58 0.3×	314 1.7×	24 0.4×	56 1.0×	18 0.3×	65	656
P. Altmann United Kingdom	13	289 1.5×	63 0.3×	44 0.7×	51 0.9×	15 0.3×	18	543
P Moscatelli Italy	14	179 0.9×	126 0.7×	62 1.0×	71 1.2×	21 0.4×	39	609
Luis I. Juncos Argentina	14	102 0.5×	78 0.4×	88 1.4×	138 2.4×	33 0.6×	35	503
Iris H.S. Chan Hong Kong	12	106 0.6×	132 0.7×	148 2.4×	196 3.4×	49 0.9×	18	774
Hequn Chen China	20	141 0.7×	187 1.0×	26 0.4×	515 9.0×	21 0.4×	81	1.1k

Countries citing papers authored by Michael S. Anger

Since Specialization

Citations

This map shows the geographic impact of Michael S. Anger's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael S. Anger with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael S. Anger more than expected).

Fields of papers citing papers by Michael S. Anger

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael S. Anger. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael S. Anger. The network helps show where Michael S. Anger may publish in the future.

Co-authorship network of co-authors of Michael S. Anger

This figure shows the co-authorship network connecting the top 25 collaborators of Michael S. Anger. A scholar is included among the top collaborators of Michael S. Anger based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael S. Anger. Michael S. Anger is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Zhang, Yan, Anke Winter, Paola Carioni, et al.. (2025). Real-world effectiveness of hemodialysis modalities: a retrospective cohort study. BMC Nephrology. 26(1). 9–9. 4 indexed citations

Ficociello, Linda, et al.. (2025). Real-world use of difelikefalin in hemodialysis patients at a large dialysis organization in the United States: a retrospective database study. BMC Nephrology. 26(1). 156–156. 1 indexed citations

Ficociello, Linda, et al.. (2023). Relative Blood Volume Monitoring Using Crit-Line and Hospital Admissions: A Retrospective Analysis of over 25,000 Patients Across 330 Dialysis Clinics. Journal of the American Society of Nephrology. 34(11S). 158–158.

Medaura, Juan, Meijiao Zhou, Linda Ficociello, Michael S. Anger, & Stuart M. Sprague. (2023). Serum Phosphorus Management with Sucroferric Oxyhydroxide as a First-Line Phosphate Binder within the First Year of Hemodialysis. American Journal of Nephrology. 55(2). 127–135.

Rhee, Connie M., et al.. (2022). A real-world analysis of the influence of age on maintenance hemodialysis patients: managing serum phosphorus with sucroferric oxyhydroxide as part of routine clinical care. International Urology and Nephrology. 55(2). 377–387. 1 indexed citations

Ficociello, Linda, Joanna Willetts, Claudy Mullon, et al.. (2022). Full and Booster Doses of SARS-CoV-2 mRNA-1273 Vaccine Increase Waning Antibody Levels After Completed Vaccination Among Dialysis Patients at a Large Dialysis Organization. International Journal of Nephrology and Renovascular Disease. Volume 15. 319–321. 1 indexed citations

Apel, Christian, et al.. (2022). Switching from high‐flux dialysis to hemodiafiltration: Cost‐consequences for patients, providers, and payers. Seminars in Dialysis. 35(5). 405–412. 2 indexed citations

Anger, Michael S., Hélène Beloeil, Philipp Lirk, et al.. (2021). PROSPECT guideline for total hip arthroplasty: a systematic review and procedure‐specific postoperative pain management recommendations. Anaesthesia. 76(8). 1082–1097. 144 indexed citations breakdown →

Kalantar‐Zadeh, Kamyar, et al.. (2021). Slipping Through the Pores: Hypoalbuminemia and Albumin Loss During Hemodialysis. International Journal of Nephrology and Renovascular Disease. Volume 14. 11–21. 36 indexed citations

10.

Ficociello, Linda, Meijiao Zhou, Claudy Mullon, Michael S. Anger, & Robert J. Kossmann. (2021). Effect of Citrate-Acidified Dialysate on Intact Parathyroid Hormone in Prevalent Hemodialysis Patients: A Matched Retrospective Cohort Study. International Journal of Nephrology and Renovascular Disease. Volume 14. 475–486. 2 indexed citations

11.

Bowry, Sudhir K., Peter Kotanko, Rainer Himmele, Xia Tao, & Michael S. Anger. (2021). The membrane perspective of uraemic toxins: which ones should, or can, be removed?. Clinical Kidney Journal. 14(Supplement_4). i17–i31. 10 indexed citations

12.

Anger, Michael S., et al.. (2020). Meeting the Demand for Renal Replacement Therapy during the COVID-19 Pandemic: A Manufacturer’s Perspective. Kidney360. 2(2). 350–354. 5 indexed citations

13.

Dwyer, Jamie P., Mohammed Sika, Gerald Schulman, et al.. (2013). Dose-Response and Efficacy of Ferric Citrate to Treat Hyperphosphatemia in Hemodialysis Patients: A Short-term Randomized Trial. American Journal of Kidney Diseases. 61(5). 759–766. 51 indexed citations

14.

Mehrotra, Rajnish, Kévin Martin, Steven Fishbane, et al.. (2008). Higher Strength Lanthanum Carbonate Provides Serum Phosphorus Control With a Low Tablet Burden and Is Preferred by Patients and Physicians. Clinical Journal of the American Society of Nephrology. 3(5). 1437–1445. 38 indexed citations

15.

Abboud, Hanna E., Daniel W. Coyne, Michael S. Anger, et al.. (2006). A Comparison of Dosing Regimens of Paricalcitol Capsule for the Treatment of Secondary Hyperparathyroidism in CKD Stages 3 and 4. American Journal of Nephrology. 26(1). 105–114. 20 indexed citations

16.

Contreras, Gabriel, Lawrence W. Elzinga, Michael S. Anger, et al.. (2003). A multicenter, prospective, randomized, comparative evaluation of dual- versus triple-lumen catheters for hemodialysis and apheresis in 485 patients. American Journal of Kidney Diseases. 42(2). 315–324. 15 indexed citations

17.

Miller, Philip, et al.. (1992). Bone histomorphometry after long-term treatment with cyclical phosphorus and etidronate. Bone and Mineral. 17. S23–S23. 2 indexed citations

18.

Miller, Paul D., et al.. (1992). Bone histomorphometry after long-term treatment with cyclical phosphorus and etidronate. Bone and Mineral. 17. 140–140. 2 indexed citations

19.

Miller, Paul D., et al.. (1991). Effect of cyclical therapy with phosphorus and etidronate on axial bone mineral density in postmenopausal osteoporotic women. Osteoporosis International. 1(3). 171–176. 22 indexed citations

20.

Anger, Michael S., et al.. (1990). Effects of lithium on cAMP generation in cultured rat inner medullary collecting tubule cells. Kidney International. 37(5). 1211–1218. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact